| human | Q5 |
| P496 | ORCID iD | 0000-0002-5151-607X |
| P1153 | Scopus author ID | 23486109100 |
| P69 | educated at | Department of Mathematics "Federigo Enriques" | Q67146961 |
| P108 | employer | University of Milan | Q46210 |
| Department of Mathematics "Federigo Enriques" | Q67146961 | ||
| P734 | family name | Meregalli | Q56539840 |
| Meregalli | Q56539840 | ||
| Meregalli | Q56539840 | ||
| P735 | given name | Mirella | Q3316024 |
| Mirella | Q3316024 | ||
| P106 | occupation | researcher | Q1650915 |
| Q54520022 | Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model. |
| Q37798837 | CD133(+) cells isolated from various sources and their role in future clinical perspectives |
| Q60313617 | CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133+ stem cells |
| Q37581545 | Cell based therapy for Duchenne muscular dystrophy |
| Q30437823 | Clinical applications of mesenchymal stem cells in chronic diseases |
| Q64008509 | Cognitive disorders in the elderly. Genetic and epigenetic aspects |
| Q61853277 | Combining stem cells and exon skipping strategy to treat muscular dystrophy |
| Q33336601 | Correlation of circulating CD133+ progenitor subclasses with a mild phenotype in Duchenne muscular dystrophy patients |
| Q39713924 | Ex vivo expansion of human circulating myogenic progenitors on cluster-assembled nanostructured TiO2. |
| Q39278027 | Expression of CD20 reveals a new store-operated calcium entry modulator in skeletal muscle |
| Q43065155 | Expression of parathyroid-specific genes in vascular endothelial progenitors of normal and tumoral parathyroid glands |
| Q42270238 | Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells |
| Q34389648 | Hmgb3 is regulated by microRNA-206 during muscle regeneration |
| Q57268519 | Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle |
| Q41091176 | Improvement of endurance of DMD animal model using natural polyphenols. |
| Q37789355 | In vivo tracking of stem cell by nanotechnologies: future prospects for mouse to human translation |
| Q33736192 | Influence of immune responses in gene/stem cell therapies for muscular dystrophies |
| Q39587585 | Novel insight into stem cell trafficking in dystrophic muscles. |
| Q33833512 | Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy. |
| Q27013613 | Perspectives of stem cell therapy in Duchenne muscular dystrophy |
| Q43769886 | Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice |
| Q40254446 | Skin-derived stem cells transplanted into resorbable guides provide functional nerve regeneration after sciatic nerve resection. |
| Q37771932 | Stem cell therapies to treat muscular dystrophy: progress to date |
| Q53242907 | The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease. |
| Q37998576 | The role of stem cells in muscular dystrophies |
| Q24294978 | VCAM-1 expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation |
Search more.